Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections
Crossref DOI link: https://doi.org/10.1186/s12879-016-2177-8
Published Online: 2017-01-14
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mukherjee, Pranab K.
Esper, Frank
Buchheit, Ken
Arters, Karen
Adkins, Ina
Ghannoum, Mahmoud A.
Salata, Robert A.
Funding for this research was provided by:
ARMS Pharmaceutical LLC (PilotTrial)
